Transcranial Direct Current Stimulation for Cognitive Deficits in Multiple Sclerosis
This study is investigating if low-level electrical stimulation, called transcranial Direct Current Stimulation (tDCS), can improve verbal memory in people with relapsing-remitting multiple sclerosis (RRMS) who have memory problems. You would receive either active tDCS or a sham (inactive) tDCS. Researchers will compare changes in your verbal memory and other thinking abilities after treatment. To join, you must be 18-65 years old, have RRMS, a memory retrieval deficit, and be fluent in English. The study aims to enroll 100 participants, but its current status is unclear.
- Study design
- This study is interventional and will randomly assign participants to either active transcranial Direct Current Stimulation (tDCS) or sham tDCS. It plans to enroll 100 participants.
- What's involved
- You would receive 10 sessions of either active or sham tDCS, each lasting 20 minutes. You will also have neuropsychological and EEG assessments at baseline, immediately after treatment, and two months later.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for two months after completing treatment to assess changes in verbal retrieval and other cognitive abilities.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Treatment of Cognitive Deficits in Multiple Sclerosis With High-Definition Transcranial Direct Current Stimulation
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- John Hart, Jr, MD · PRINCIPAL_INVESTIGATOR · The University of Texas at Dallas
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Exclusion
What this trial measures
- Treatment group differences in change from Baseline to 1-week Post-Treatment on Category FluencyOutcome measures will be assessed as change over a period of 6 weeks: Change from baseline to 1-week Post-Treatment
Evaluation of treatment group differences in change on Category Fluency from baseline to 1-week post-treatment. Metric: Number of Correct Items Generated
- Treatment group differences in change from Baseline to 2-months Post-Treatment on Category FluencyOutcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-month Post-Treatment
Evaluation of treatment group differences in change on Category Fluency from baseline to 2-months post-treatment. Metric: Number of Correct Items Generated
- Treatment group differences in change from Baseline to 1-week Post-Treatment on COWATOutcome measures will be assessed as change over a period of 6 weeks: Change from baseline to 1-week Post-Treatment
Evaluation of treatment group differences in change on COWAT from baseline to 1-week post-treatment. Metric: Number of Correct Items Generated
- Treatment group differences in change from Baseline to 2-months Post-Treatment on COWATOutcome measures will be assessed as change over a period of 13 weeks: Change from baseline to 2-months Post-Treatment
Evaluation of treatment group differences in change on COWAT from baseline to 2-months post-treatment. Metric: Number of Correct Items Generated